Daily roundupMonday's key coronavirus developments from Luxembourg and abroad
Find all of today's most important Covid developments both at home and abroad in one place.
Starting with Luxembourg
And abroad
Vaccination is highly effective at preventing severe cases of Covid-19, even against the Delta variant, a vast study in France has shown. The research looked at 22 million people over 50. It is the largest study of its kind - more here.
- US pharmaceutical giant Merck on Monday applied for emergency use authorisation of its oral anti-Covid drug in the United States, a major step towards finding a simple pill to treat the disease.
- British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms. The drug, made from a combination of two antibodies, achieved a “statistically significant reduction in severe Covid-19 or death” in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement.
- New Zealand announced Monday a sweeping “no jab, no job” policy for most healthcare workers and teachers to prevent the spread of Covid-19.
- The historic Hong Kong Open golf was postponed for a second consecutive year due to the coronavirus pandemic with suitable dates for “early 2022" under consideration, organisers said on Monday.